Oscar Health (OSCR) has moved into focus after Zacks assigned the stock its highest Rank #1, along with a higher consensus earnings estimate over the past two months and a PEG ratio below the industry average.

At a share price of $31.24, Oscar Health has shown strong momentum, with a 30 day share price return of 10.23%, a 90 day share price return of 39.90%, and a year to date share price return of 108.68%, alongside a 3 year total shareholder return of about 4x. This points to investors increasingly pricing in its growth profile and reassessing risk as Zacks highlights the stock with a Rank #1 and rising earnings expectations.

Spot other fast moving growth stories alongside Oscar Health by scanning our hand picked 20 high quality undiscovered gems.

That surge in Oscar Health now leaves a key issue on your plate. Is the market rewarding a healthier earnings and growth profile, or has sentiment simply sprinted ahead of the fundamentals as we look at valuation next?

Most Popular Narrative: 94.6% Undervalued

The most followed narrative on Oscar Health values the stock at a fair value of $583.34, far above the last close at $31.24. That wide gap is built on a very specific set of growth and cash flow assumptions that go well beyond current market pricing.

Every so often, a ticker flashes on my screen that makes me stop and rub my eyes. It is the kind of number that look like a mistake, like you thought you were getting clothes on Christmas Day, but then your parents surprise you by hiding the PlayStation 2 you've been wanting for months in the other room...

The screen showed Oscar Health. Ridiculous name for a health insurance company, but the numbers are anything but.

Want to see why this narrative pushes Oscar Health so far above today’s price? It leans on aggressive long term revenue compounding, rich profitability and a premium earnings multiple that are anything but ordinary.

The narrative, according to J_Tyrader, rests on a detailed discounted cash flow build that assumes strong expansion in Oscar Health's cash generation and a long runway before growth slows. It also layers in sensitivity checks on growth and discount rates that still leave the fair value far above where the stock trades today.

Result: Fair Value of $583.34 (UNDERVALUED)

However, this Oscar Health narrative relies heavily on very high future growth and cash conversion assumptions, so any revenue slowdown or margin pressure could quickly erode that upside case.

Next Steps

With sentiment on Oscar Health pulled between optimism and caution, the best move is to review the numbers yourself and act promptly. Start by weighing both sides of the story through the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Oscar Health?

If Oscar Health has caught your attention, do not stop here. Broaden your watchlist now and give yourself more options before the next move happens.

• Spot potential value opportunities early by scanning our hand picked 51 high quality undervalued stocks that align with strong fundamentals and disciplined pricing.
• Build a sturdier core to your portfolio by reviewing the list of solid balance sheet and fundamentals (51 results) and focusing on companies with healthier financial footing.
• Lower the chance of unpleasant surprises by checking out the 75 resilient stocks with low risk scores designed to highlight businesses with more measured risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.